U.S. halts Johnson and Johnson’s COVID-19 vaccine due to rare clot risk
(REUTERS) – U.S. federal health agencies have paused the use of Johnson & Johnson’s COVID-19 vaccine. The decision follows the cases of six women under the age of 50 who developed rare blood clots after receiving their shots and deals a fresh setback in efforts to tackle the pandemic.... Read more